An Integrated Approach to Tumour Profiling Brochure
Classifying tumours by genetic make-up, rather than by which organ is affected, is changing the approach to cancer.
The determination of mutation type — including single point mutations, translocations, copy number variations (CNV) or loss of heterozygosity (LOH) — can guide research into diagnostic and prognostic applications, and allow for truly personalised treatment options. This genetic information is the basis for the rapidly developing field of precision medicine.
Various technologies are available to study the mutations that cause cancer, but none is capable of accurate detection of all types of genetic aberrations. By combining information from multiple technologies, researchers can analyse complex cancer samples and get the most complete overview of disease-driving mutations.